Key result
Experimental diabetes causes ~2-fold greater subendocardial fibrosis and inflammation compared to interstitial myocardium.
Why the study?
Does streptozotocin-induced diabetes cause differential oxidative stress, inflammation, and fibrosis in subendocardial versus interstitial myocardial areas in male Wistar rats?
Does streptozotocin-induced diabetes cause differential oxidative stress, inflammation, and fibrosis in subendocardial versus interstitial myocardial areas in male Wistar rats?
The subendocardial myocardium is more susceptible to oxidative stress, inflammation, and fibrosis than the interstitial area in a rat model of diabetic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
Subendocardial susceptibility in diabetic rats is hypothesis-generating; leaves open human translation and precludes practice change.
Diabetic cardiomyopathy (DCM) is characterized by cardiac remodeling and impaired diastolic function that may lead to heart failure. The aim of this study was to evaluate oxidative stress, inflammatory cells, and fibrosis in both subendocardial (SEN) and interstitial (INT) areas of the myocardium. Male Wistar rats were allocated to 2 groups of 9 animals, a control (CT) group and streptozotocin-induced diabetes (DM). After 8 weeks, echocardiography morphometry, protein expression, and confocal microscopy in SEN and INT areas of the left ventricle (LV) were performed. The echocardiographic analysis showed that diabetes induction leads to cardiac dilation, hypertrophy, and LV diastolic dysfunction. As compared to CT, the induction of diabetes increased inflammatory cells and fibrosis in both SEN and INT areas of DM myocardium and increased ROS generation only in SEN. Comparing the SEN and INT areas in the DM group, inflammatory cells and fibrosis in SEN were greater than in INT. In conclusion, diabetic myocardium SEN area, wherein oxidative stress was more pronounced, is more susceptible to cardiac dysfunction than INT area. This finding can be important for the understanding of the heart remodeling process occurring in DCM and perhaps to engender targeted therapies to attenuate or revert DCM-related diastolic dysfunction.
No takes yet. Share an insight, caveat, or question.
Guido et al. (2017) studied Diabetic cardiomyopathy (n=18). Streptozotocin-induced diabetes vs. Citrate buffer vehicle control was evaluated on Oxidative stress (ROS generation), inflammatory cell infiltration, and myocardial fibrosis in subendocardial (SEN) versus interstitial (INT) left ventricular areas (p=<0.05). Streptozotocin-induced diabetes in rats increased subendocardial fibrosis and inflammatory cells twofold compared to interstitial areas (p<0.05) and elevated subendocardial ROS (p<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: